Clinical trial
GnRH Antagonist to Prepare Recipients for Embryo Transfer
NCT00460642 · Institute for Human Reproduction (IHR), Other · Completed
Key facts
| NCT number | NCT00460642 |
|---|---|
| Title | GnRH Antagonist to Prepare Recipients for Embryo Transfer |
| Official title | Use of GnRH Antagonist (Cetrotide) Protocol, Instead of Agonist, to Prepare Recipients for Embryo Transfer |
| Lead sponsor | Institute for Human Reproduction (IHR), Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | GnRH Antagonist (Cetrotide) |
| Enrollment | 130 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 16, 2007 |
| Last update posted | May 26, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: